Cargando…
Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients
BACKGROUND AND OBJECTIVES: An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness in treatment has been investigated. In this study; it was aimed to inv...
Autores principales: | Okumuş, Nurullah, Demirtürk, Neşe, Çetinkaya, Rıza Aytaç, Güner, Rahmet, Avcı, İsmail Yaşar, Orhan, Semiha, Konya, Petek, Şaylan, Bengü, Karalezli, Ayşegül, Yamanel, Levent, Kayaaslan, Bircan, Yılmaz, Gülden, Savaşçı, Ümit, Eser, Fatma, Taşkın, Gürhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093585/ https://www.ncbi.nlm.nih.gov/pubmed/33947344 http://dx.doi.org/10.1186/s12879-021-06104-9 |
Ejemplares similares
-
Adverse effects of oral antiviral therapy in chronic hepatitis B
por: Kayaaslan, Bircan, et al.
Publicado: (2017) -
COVID-19 and the liver: A brief and core review
por: Kayaaslan, Bircan, et al.
Publicado: (2021) -
Investigation of the relation between risk assessment of exposure and nosocomial SARS-CoV-2 transmission in healthcare workers: a prospective single-centre study
por: Kaya Kalem, Ayse, et al.
Publicado: (2022) -
Effect of 2 Different High-Dose Methylprednisolone Treatments on Clinical Outcomes in Severe COVID-19 Patients
por: Eser, Fatma, et al.
Publicado: (2023) -
Comparison of the Characteristics of Brucella Patients Diagnosed With Blood Culture Positivity and/or Serology
por: Konya, Petek, et al.
Publicado: (2023)